Visudyne Verteporfin Injection is a specialized treatment designed for patients suffering from age-related macular degeneration (AMD) and choroidal neovascularization (CNV). This photosensitizing agent is activated by non-thermal laser light, precisely targeting and sealing abnormal blood vessels in the eye, preventing further vision loss.
Visudyne works by accumulating in these abnormal blood vessels, where it produces reactive oxygen species when exposed to laser light, leading to vessel closure and reduced fluid leakage.
Ideal for those at risk of vision loss due to AMD or pathological myopia, Visudyne offers a targeted approach to treatment, minimizing damage to surrounding healthy tissues. Its precise action helps preserve as much vision as possible, making it a crucial part of managing serious eye conditions. The treatment is typically administered by a healthcare professional in a clinical setting, ensuring proper dosage and application.
